Loading…
Nexalin Technology, Inc. is projected to rise to $0.6366 by 2027, a +41% move from its current price of $0.452. NXL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.4266 | $0.452 | $0.479 | 0.00% |
| Jul 14 | $0.4164 | $0.452 | $0.4906 | 0.00% |
| Jul 15 | $0.4088 | $0.452 | $0.4998 | +0.01% |
| Jul 16 | $0.4026 | $0.452 | $0.5076 | +0.01% |
| Jul 17 | $0.3971 | $0.452 | $0.5146 | +0.01% |
| Jul 18 | $0.3922 | $0.4521 | $0.521 | +0.01% |
| Jul 19 | $0.3878 | $0.4521 | $0.527 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3878 | $0.4521 | $0.527 | +0.01% |
| Week 2 | $0.364 | $0.4521 | $0.5616 | +0.03% |
| Week 3 | $0.3467 | $0.4522 | $0.5898 | +0.04% |
| Week 4 | $0.3328 | $0.4523 | $0.6146 | +0.06% |
| Week 5 | $0.321 | $0.4523 | $0.6374 | +0.07% |
| Week 6 | $0.3107 | $0.4524 | $0.6587 | +0.09% |
| Week 7 | $0.3015 | $0.4525 | $0.6789 | +0.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China.
The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Nexalin Technology, Inc. is headquartered in Houston, Texas.
Nexalin Technology, Inc. (NXL) operates in the Healthcare sector as a medical device company that designs and develops neurostimulation products.
The current price is $0.452, and the company has a market cap of $9.74M. Its market position is reflected by a rank of 5145.
The forecast projects a path higher over the coming years, with the average price rising from $0.452 in 2026 to $1.76 in 2050 and higher maximums in later years, such as $1.95 (2034) and $3.17 (2040), up to $4.04 (2050).
Overall, the outlook suggests upside potential against a backdrop of volatility common to small-cap healthcare stocks.
A major floor 58.6% below — a decisive break under it would weaken the trend.
The nearest floor, 27.0% below — buyers have tended to step in here.
The nearest ceiling, 35.0% above — a clean break opens room to run.
A major ceiling 65.3% above — clearing it would confirm fresh momentum.
Key NXL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NXL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4082 | Buy | $0.4216 | Buy |
| MA 10 | $0.381 | Buy | $0.4006 | Buy |
| MA 20 | $0.384 | Buy | $0.3992 | Buy |
| MA 50 | $0.4075 | Buy | $0.4137 | Buy |
| MA 100 | $0.4164 | Buy | $0.4719 | Sell |
| MA 200 | $0.6885 | Sell | $0.6616 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.20 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 146.67 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 28.06 | Buy |
| Bollinger %B (20,2) | 0.96 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.61 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 72.55 | Sell |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 0.45 | Buy |
| ADX (14) | 19.30 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture shows bullish sentiment, with RSI14 at 60.
The 50-day simple moving average is $0.4057 and the 200-day simple moving average is $0.691.
Support is at $0.33 and resistance is at $0.61, with the 30-day price range between $0.3052 and $0.6694.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.321 | $0.452 | $0.6538 | 0% | Neutral | |
| $0.4618 | $0.6366 | $0.9489 | +41% | Bullish | |
| $0.4583 | $0.6713 | $1.07 | +49% | Bullish | |
| $0.3967 | $0.6122 | $1.02 | +35% | Bullish | |
| $0.3428 | $0.5545 | $0.9625 | +23% | Bullish | |
| $0.3669 | $0.6203 | $1.11 | +37% | Bullish | |
| $0.3789 | $0.6683 | $1.24 | +48% | Bullish | |
| $0.4729 | $0.8685 | $1.65 | +92% | Bullish | |
| $0.5295 | $1.01 | $1.97 | +124% | Bullish | |
| $0.4566 | $0.9067 | $1.81 | +101% | Bullish | |
| $0.6615 | $1.47 | $3.23 | +225% | Bullish | |
| $0.8057 | $1.79 | $4.12 | +296% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.321 | $0.452 | $0.559 | +0.00% |
| August 2026 | $0.3598 | $0.436 | $0.5504 | -3.53% |
| September 2026 | $0.3685 | $0.4528 | $0.5836 | +3.86% |
| October 2026 | $0.3939 | $0.49 | $0.6424 | +8.20% |
| November 2026 | $0.3863 | $0.4856 | $0.6459 | -0.89% |
| December 2026 | $0.3823 | $0.4852 | $0.6538 | -0.08% |
Click any year to see its month-by-month NXL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NXL to range from $0.321 to $0.6538 through 2026. The $0.452 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The NXL price prediction for 2027 points to an average of $0.6366 (low $0.4618, high $0.9489) — a potential gain of +41% on today's $0.452. Momentum favours further upside here.
In 2028, NXL is projected to trade between $0.4583 and $1.07, averaging $0.6713 — a potential gain of +49% from today's $0.452. That is up +5% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Nexalin Technology, Inc.'s 2029 outlook centres on $0.6122, within a $0.3967 to $1.02 range. That is -9% versus the projected 2028 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2030, NXL could reach as high as $0.9625, with a base case around $0.5545 and support toward $0.3428 — roughly +23% from $0.452. Buyers look set to stay in control over this stretch.
Expect NXL to range from $0.3669 to $1.11 through 2031. The $0.6203 average target implies a +37% move from current prices. That is up +12% on the projected 2030 average. Momentum favours further upside here.
The NXL price prediction for 2032 points to an average of $0.6683 (low $0.3789, high $1.24) — a potential gain of +48% on today's $0.452. Buyers look set to stay in control over this stretch.
In 2033, NXL is projected to trade between $0.4729 and $1.65, averaging $0.8685 — a potential gain of +92% from today's $0.452. That is up +30% on the projected 2032 average. Momentum favours further upside here.
Nexalin Technology, Inc.'s 2034 outlook centres on $1.01, within a $0.5295 to $1.97 range. That is up +16% on the projected 2033 average. That marks a +124% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, NXL could reach as high as $1.81, with a base case around $0.9067 and support toward $0.4566 — roughly +101% from $0.452. Momentum favours further upside here.
Expect NXL to range from $0.6615 to $3.23 through 2040. The $1.47 average target implies a +225% move from current prices. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The NXL price prediction for 2050 points to an average of $1.79 (low $0.8057, high $4.12) — a potential gain of +296% on today's $0.452. Momentum favours further upside here.
Investing $1,000 in NXL today (≈ 2,212.389381 NXL) could be worth
$3,961.23
+$2,961.23 (+296%) by 2050 · US Dollar
Based on the average projected NXL price of $1.79 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NXLwould be worth at today's price.
$1,000 invested in NXL on Jul 10, 2025 (≈ 1,004.016072 NXL) would be worth
$453.82
-$546.18 (-54.6%) today · 0.45× · US Dollar
Based on a NXL entry price of $0.996 vs. today's $0.452.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.361 | $1,252.08 | +25.2% |
| 1 month ago | $0.459 | $984.75 | -1.5% |
| 3 months ago | $0.402 | $1,124.38 | +12.4% |
| 6 months ago | $0.71 | $636.62 | -36.3% |
| 1 year ago | $0.996 | $453.82 | -54.6% |
| All time (3.8y) ago | $2.25 | $200.89 | -79.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NXL forecast.
Our base-case forecast reaches $0.90 around 2034.
Implied market cap at $0.90: $19.39M
The multi-year forecast spans 2026 through 2050, with 2026 listed as neutral (min $0.321, avg $0.452, max $0.6534; ROI 0).
From 2027 onward, the outlook turns bullish, with 2027 avg $0.6373 and ROI 41, 2028 avg $0.6685 and ROI 47.9, 2029 avg $0.6108 and ROI 35.1, and 2030 avg $0.5535 and ROI 22.5.
The sequence continues with 2031 avg $0.6139 ROI 35.8, 2032 avg $0.6593 ROI 45.9, 2033 avg $0.8572 ROI 89.6, 2034 avg $0.9983 ROI 120.9, and 2035 avg $0.8976 ROI 98.6, all described as BULLISH.
Longer horizon projections show 2040 avg $1.44 ROI 219 and 2050 avg $1.76 ROI 288.4, with max values reaching $1.95 in 2034, $3.17 in 2040, and $4.04 in 2050.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $0.5535 with a low of $0.3421 and a high of $0.9609; ROI 22.5; sentiment BULLISH.
The forecast shows bullish sentiment in multiple years after 2026, with average prices and ROIs such as 2027 avg $0.6373 ROI 41 and 2040 avg $1.44 ROI 219, 2050 avg $1.76 ROI 288.4. These figures illustrate potential upside but are estimates, not guarantees.
Yes, the forecast maximums reach $1.95 in 2034, then rise to $3.17 by 2040 and $4.04 by 2050.
The current price is $0.452 and the market cap is $9.74M; the rank is 5145.
The 30-day range is from $0.3052 to $0.6694.
Nexalin Technology, Inc. Community Discussion
0Share your Nexalin Technology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.